Humana Inc. (HUM) Upgraded at JPMorgan Chase & Co.
Humana Inc. (NYSE:HUM) was upgraded by stock analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Thursday.
Other research analysts have also recently issued research reports about the stock. Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and increased their target price for the stock from $158.89 to $210.00 in a report on Monday, July 18th. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $197.00 target price for the company in a report on Monday, July 25th. RBC Capital Markets reaffirmed a “buy” rating and set a $224.00 price target (up from $220.00) on shares of Humana in a research report on Friday, July 22nd. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Humana in a research report on Monday, August 8th. Finally, Evercore ISI started coverage on shares of Humana in a research report on Thursday, September 22nd. They set a “buy” rating and a $200.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $199.71.
Shares of Humana (NYSE:HUM) opened at 186.00 on Thursday. Humana has a 52-week low of $150.00 and a 52-week high of $191.65. The firm has a 50-day moving average of $174.45 and a 200 day moving average of $175.39. The firm has a market capitalization of $27.73 billion, a price-to-earnings ratio of 25.15 and a beta of 0.80.
Humana (NYSE:HUM) last announced its earnings results on Friday, November 4th. The insurance provider reported $3.18 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.09 by $0.09. Humana had a net margin of 2.00% and a return on equity of 12.32%. The business earned $13.69 billion during the quarter, compared to analysts’ expectations of $13.41 billion. During the same quarter in the prior year, the company posted $2.16 earnings per share. The firm’s revenue was up 2.5% on a year-over-year basis. Analysts predict that Humana will post $9.45 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Thursday, January 12th will be paid a dividend of $0.29 per share. The ex-dividend date is Tuesday, January 10th. This represents a $1.16 dividend on an annualized basis and a yield of 0.62%. Humana’s payout ratio is 15.96%.
A number of large investors have recently made changes to their positions in HUM. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Humana during the second quarter worth about $126,000. Daiwa SB Investments Ltd. increased its stake in shares of Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock worth $129,000 after buying an additional 10 shares during the last quarter. People s United Financial Inc. increased its stake in shares of Humana by 141.6% in the third quarter. People s United Financial Inc. now owns 853 shares of the insurance provider’s stock worth $151,000 after buying an additional 500 shares during the last quarter. Markston International LLC purchased a new stake in shares of Humana during the third quarter worth about $159,000. Finally, Bessemer Group Inc. increased its stake in shares of Humana by 14.0% in the second quarter. Bessemer Group Inc. now owns 1,140 shares of the insurance provider’s stock worth $205,000 after buying an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 93.43% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.